Aminoglycoside - PharmaKB

Aminoglycoside

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2994 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Breast neoplasms	D001943	EFO_0003869	C50	70	301	166	12	43	549
Lymphoma	D008223	—	C85.9	75	247	105	10	16	406
Myeloid leukemia acute	D015470	—	C92.0	130	200	84	9	16	374
Leukemia	D007938	—	C95	86	196	99	23	17	371
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	37	124	60	23	18	241
Sarcoma	D012509	—	—	53	94	44	1	13	184
Large b-cell lymphoma diffuse	D016403	—	C83.3	45	101	35	2	5	159
Non-hodgkin lymphoma	D008228	—	C85.9	38	89	39	3	6	153
Myeloid leukemia	D007951	—	C92	52	84	33	4	7	145
Neoplasms	D009369	—	C80	67	50	15	3	4	121

Show 109 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Triple negative breast neoplasms	D064726	—	—	18	71	15	—	5	100
Ovarian neoplasms	D010051	EFO_0003893	C56	20	26	15	—	1	56
Recurrence	D012008	—	—	26	26	7	—	3	53
Stomach neoplasms	D013274	EFO_0003897	C16	9	28	11	—	5	48
Neuroblastoma	D009447	EFO_0000621	—	8	21	15	—	2	46
Monocytic leukemia acute	D007948	—	—	11	25	12	—	1	43
Myelomonocytic leukemia acute	D015479	—	C92.5	10	23	11	—	1	40
Neoplasm metastasis	D009362	EFO_0009708	—	12	20	6	—	2	36
Erythroblastic leukemia acute	D004915	EFO_1001257	C94.0	9	20	11	—	1	36
Megakaryoblastic leukemia acute	D007947	—	C94.2	8	19	11	—	1	34

Show 192 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Blast crisis	D001752	—	—	4	9	—	—	—	12
Plasmablastic lymphoma	D000069293	—	C83.3	7	6	—	—	—	11
Invasive hydatidiform mole	D002820	—	D39.2	—	8	—	—	—	8
Aids-related lymphoma	D016483	EFO_1001365	—	4	5	—	—	—	8
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	4	4	—	—	—	7
Fibrosis	D005355	—	—	2	3	—	—	3	7
Head and neck neoplasms	D006258	—	—	4	5	—	—	1	7
Acute disease	D000208	—	—	3	3	—	—	—	6
Myeloid leukemia chronic-phase	D015466	—	—	3	3	—	—	—	6
Primary effusion lymphoma	D054685	—	C83.8	5	4	—	—	—	6

Show 156 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Diabetes mellitus	D003920	EFO_0000400	E08-E13	2	—	—	—	2	4
Appendiceal neoplasms	D001063	EFO_0003880	C18.1	2	—	—	—	1	3
Pregnancy	D011247	EFO_0002950	Z33.1	1	—	—	—	1	2
Cystadenocarcinoma	D003536	—	—	2	—	—	—	—	2
Ulcerative colitis	D003093	EFO_0000729	K51	1	—	—	—	1	2
Colitis	D003092	EFO_0003872	K52.9	1	—	—	—	1	2
Ulcer	D014456	MPATH_579	—	1	—	—	—	1	2
Neoplasms by histologic type	D009370	—	—	2	—	—	—	—	2
Chronic renal insufficiency	D051436	—	N18	1	—	—	—	1	2
Female genital neoplasms	D005833	—	—	2	—	—	—	—	2

Show 28 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Acute kidney injury	D058186	—	N17	—	—	—	—	5	5
Cardiovascular diseases	D002318	EFO_0000319	I98	—	—	—	—	4	4
Myopia	D009216	EFO_0003927	H52.1	—	—	—	—	3	3
Astigmatism	D001251	EFO_0004222	H52.2	—	—	—	—	2	2
Hypertension	D006973	EFO_0000537	I10	—	—	—	—	2	2
Gram-negative bacterial infections	D016905	—	—	—	—	—	—	2	2
Pulmonary tuberculosis	D014397	EFO_1000049	A15	—	—	—	—	2	2
Liver cirrhosis	D008103	EFO_0001422	K74.0	—	—	—	—	2	2
Diabetic neuropathies	D003929	EFO_1000783	—	—	—	—	—	2	2
Chronic bronchitis	D029481	—	J42	—	—	—	—	1	1

Show 123 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	—
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—